Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians

References

• Arslan S. 2010. Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. Biochem Genet. 48(11–12):987–994. doi:10.1007/s10528-010-9387-3.
   PubMed Web of Science ®Google Scholar
• Bahl C, Sharma S, Singh N, Behera D. 2017. AssoCiation study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: a multiple interaction analysis. Tumor Biol. 39(4):1–18.
   Google Scholar
• Berrandou T, Mulot C, Cordina-Duverger E, Arveux P, Laurent-Puig P, Truong T, Guénel P. 2019. AssoCiation of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: a gene‐set analysis. Int J Cancer. 144(8):1896–1908. doi:10.1002/ijc.31917.
   PubMed Web of Science ®Google Scholar
• Brockstedt U, Krajinovic M, Richer C, Mathonnet G, Sinnett D, Pfau W, Labuda D. 2002. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs). Mutation Research/Genet Toxicol Environ Mutagen. 516(1–2):41–47. doi:10.1016/S1383-5718(02)00019-0.
   PubMed Web of Science ®Google Scholar
• Clemens MR. 1991. Free radicals in chemical carCinogenesis. 1991. Klin Wochenschr. 21:1123–1134. doi:10.1007/BF01645172.
   Google Scholar
• Coroller TP, Agrawal V, Narayan V, Hou Y, Grossmann P, Lee SW, Mak RH, Aerts HJ. 2016. Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol. 119(3):480–486. doi:10.1016/j.radonc.2016.04.004.
   PubMed Web of Science ®Google Scholar
• de Groot P, Munden RF. 2012. Lung cancer epidemiology, risk factors, and prevention. Radiologic Clin. 50(5):863–876.
   PubMed Web of Science ®Google Scholar
• Ghattas MH, Amer MA. 2012. Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus. Endocrine. 42(3):577–583. doi:10.1007/s12020-012-9656-5.
   PubMed Web of Science ®Google Scholar
• Girdhar Y, Singh N. Digambar Behera & Siddharth Sharma. 2016a. Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers. Int J Biol Markers. 31(4):e402–412.
   PubMed Web of Science ®Google Scholar
• Girdhar Y, Singh N, Behera D, Sharma S. 2016b. Combinations of the variant genotypes of CYP1A1, GSTM1 and GSTT1 are associated with an increased lung cancer risk in North Indian population: a case-control study. Pathol Oncol Res. 22(3):647–652. doi:10.1007/s12253-016-0058-5.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. 1999. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 39:1.
   PubMed Web of Science ®Google Scholar
• Justenhoven C. 2012. Polymorphisms of Phase I and phase II enzymes and breast cancer risk. Front Genet. 3:258. doi:10.3389/fgene.2012.00258.
   PubMedGoogle Scholar
• Kaur Walia H, Verma U, Singh N, Siddharth Sharma. 2019. Polymorphisms in GSTM1 and GSTT1 influence response and treatment outcome in lung cancer patients treated with platinum-based chemotherapy. Br J Biomed Sci. 76(4):198–200.
   PubMed Web of Science ®Google Scholar
• Lotfi F, Bahrehmand F, Vaisi-Raygani A, Khodarahmi R, Tanhapour M, Kiani A, Rahimi Z, Pourmotabbed T. 2018. Cytochrome P450 (CYP450, 2D6* A), N-Acetyltransferase-2 (NAT2* 7, A) and Multidrug Resistance 1 (MDR1 3435 T) alleles collectively increase risk of ulcerative colitis. Archives Iran mediCineCIArchives Iran mediCine. 21(11):530–535.
   PubMed Web of Science ®Google Scholar
• Mandal RK, Nissar K, Mittal RD. 2012. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India. Mol Biol Rep. 12:11145–11152.
   Google Scholar
• Mota P, Silva HC, Soares MJ, Pego A, Loureiro M, Cordeiro CR, Regateiro FJ. 2015. Genetic polymorphisms of Phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. J Cancer Res Clin Oncol. 141(5):851–860. doi:10.1007/s00432-014-1868-z.
   PubMed Web of Science ®Google Scholar
• Ritchie MD, Motsinger AA. 2005. Multifactor dimensionality reduction for detecting gene–gene and gene–environment interactions in pharmacogenomics studies. Pharmacogenomics. 6(8):823–834. doi:10.2217/14622416.6.8.823.
   PubMed Web of Science ®Google Scholar
• Sharma N, Singh A, Singh N, Behera D, Siddharth S. 2015. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiol. 39(6):947–955.
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S et al. 2012. Cancer treatment and survivorship statistics, 2012. Cancer J cliniCiansCICancer J cliniCians. 62(4):220–241. doi:10.3322/caac.21149.
   PubMed Web of Science ®Google Scholar
• Skjelbred CF, Svendsen M, Haugan V, Eek AK, Clausen KO, Kure EH, Tuimala JT, Svendsen MV, Norppa H, Hansteen IL. 2011. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequenCies in human lymphocytes. CarCinogenesis. 32(3):399–405.
   PubMed Web of Science ®Google Scholar
• Sørensen M, Autrup H, Tjønneland A, Overvad K, Raaschou-Nielsen O. 2005. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett. 221(2):185–190. doi:10.1016/j.canlet.2004.11.012.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B, Toland AE. 2012. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One. 7(7):e40162. doi:10.1371/journal.pone.0040162.
   PubMed Web of Science ®Google Scholar
• Tian G, Wang M, Xu X. 2014. The role of NQO1 polymorphisms in the susceptibility and chemotherapy response of Chinese NSCLC patients. Cell Biochem Biophys. 69(3):475–479. doi:10.1007/s12013-014-9820-z.
   PubMed Web of Science ®Google Scholar
• Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, Jäger B, Mittelstrass K, Dienemann H, LUCY‐Consortium, Bartsch H. 2010. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early‐onset lung cancer. Int J Cancer. 127(7):1547–1561. LUCY‐Consortium.
   PubMed Web of Science ®Google Scholar
• Turesky RJ. 2004. The role of genetic polymorphisms in metabolism of carCinogenic heterocyclic aromatic amines. Curr Drug Metab. 5(2):169–180.
   PubMed Web of Science ®Google Scholar
• Walia HK, Singh N, Sharma S. 2021. Genetic polymorphism of Arg213His variant in the SULT1A1 gene is assoCiated with reduced susceptibility to lung cancer in North Indian population. Xenobiotica. 51(9):1071–1080. doi:10.1080/00498254.2021.1963008.
   PubMed Web of Science ®Google Scholar
• Windmill KF, McKinnon RA, Zhu X, Gaedigk A, Grant DM, McManus ME 1997. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 376(1–2):153–160. doi:10.1016/S0027-5107(97)00038-9.
   PubMed Web of Science ®Google Scholar
• Yang CS, Smith TJ, Hong JY. 1994. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carCinogenesis and toxiCity: opportunities and limitations. Cancer Res. 54(7_Supplement):1982s–1986s.
   PubMed Web of Science ®Google Scholar
• Yu W, Lin Z, Qu B. 2015. Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations. Cell Biochem Biophys. 71(2):813–820. doi:10.1007/s12013-014-0268-y.
   PubMed Web of Science ®Google Scholar
• Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A. 2008. A comprehensive analysis of Phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. CarCinogenesis. 29(6):1164–1169. doi:10.1093/carcin/bgn020.
   PubMed Web of Science ®Google Scholar